FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

385055001: Tablet (basic dose form)

  • SNOMED CT Concept\Qualifier value\Basic dose form (basic dose form)\Solid dose form\A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition.

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1479317011 Tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3534602016 Tablet (basic dose form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3635452013 A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. en Definition Active Entire term case sensitive (core metadata concept) SNOMED CT core
1459233010 Tablet (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1479317011 Tablet en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1479317011 Tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2536656014 Tablets en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2536656014 Tablets en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2613089014 Tablet dose form (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2660323018 Tablet dose form (qualifier value) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2660323018 Tablet dose form (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2770896013 Tablet dose form en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2770896013 Tablet dose form en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3534602016 Tablet (basic dose form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3635452013 A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. en Definition Active Entire term case sensitive (core metadata concept) SNOMED CT core
13111000188116 comprimé fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
13111000188116 comprimé fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

3 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Is a Type of drug preparation false Inferred relationship Existential restriction modifier (core metadata concept)
A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Is a Oral dose form false Inferred relationship Existential restriction modifier (core metadata concept)
A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Is a Solid dose form true Inferred relationship Existential restriction modifier (core metadata concept)
A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Has state of matter (attribute) Solid (state of matter) true Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group
Allopurinol 300 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Colchicine 500 microgram oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Sulfinpyrazone 100mg tablet (substance) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Sulfinpyrazone 200 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Neostigmine bromide 15 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Baclofen 10 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Carisoprodol 125 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Carisoprodol 350 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Methocarbamol 750 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Tizanidine (as tizanidine hydrochloride) 2 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Tizanidine (as tizanidine hydrochloride) 4 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Acetazolamide 250 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Pilocarpine hydrochloride 5mg tablet (substance) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Cyproterone acetate 2 mg and ethinylestradiol 35 microgram oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Potassium permanganate 400mg tablet for solution Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely pyridostigmine bromide 60 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Meptazinol 200mg tablet (substance) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Amoxycillin trihydrate 200mg tablet disperdose for oral suspension Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Amoxycillin trihydrate 400mg tablet disperdose for oral suspension Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Rosuvastatin (as rosuvastatin calcium) 5 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely conjugated estrogen 900 microgram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Conjugated estrogen 450 microgram oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely conjugated estrogen 300 microgram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone (as rosiglitazone maleate) 1 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Metformin hydrochloride 500 mg and rosiglitazone (as rosiglitazone maleate) 2 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely metformin hydrochloride 1 gram and rosiglitazone (as rosiglitazone maleate) 2 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely metformin hydrochloride 1 gram and rosiglitazone (as rosiglitazone maleate) 4 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing only clozapine orally disintegrating 25 mg/1 each oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing only clozapine orally disintegrating 100 mg/1 each oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Lansoprazole 15mg m/r capsule/naproxen 375mg tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Lansoprazole 15mg m/r capsule/naproxen 500mg tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Escitalopram (as escitalopram oxalate) 5 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely clozapine 12.5 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Amoxicillin 600mg tablet for oral suspension Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Fexofenadine hydrochloride+pseudoephedrine hydrochloride 180mg/240mg m/r tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Paroxetine mesylate 10mg tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Paroxetine mesylate 20mg tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Paroxetine mesylate 30mg tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Paroxetine mesylate 40mg tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Candesartan cilexetil 32 mg and hydrochlorothiazide 12.5 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Hydrochlorothiazide 12.5 mg and olmesartan medoxomil 20 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Hydrochlorothiazide 12.5 mg and olmesartan medoxomil 40 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Olmesartin medoxomil 40mg/hydrochlorothiazide 25mg tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely glibenclamide 1.25 milligram and metformin hydrochloride 250 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely glibenclamide 2.5 milligram and metformin hydrochloride 500 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely glibenclamide 5 milligram and metformin hydrochloride 500 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely desogestrel 100 microgram and ethinylestradiol 25 microgram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely carbinoxamine 4 milligram/1 each conventional release oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely ibandronate sodium 2.5 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Memantine hydrochloride 5 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely cefaclor 125 milligram/1 each conventional release chewable tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Cefaclor 187 mg chewable tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Cefaclor 250mg chewable tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely cefaclor 375 milligram/1 each conventional release chewable tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely metoprolol tartrate 25 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Cyclobenzaprine hydrochloride 5 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Methamphetamine hydrochloride 5mg m/r tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Methamphetamine hydrochloride 10mg m/r tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Methamphetamine hydrochloride 15mg m/r tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Hydrochlorothiazide 25 mg and valsartan 160 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely ethinylestradiol 5 microgram and norethisterone acetate 1 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Fenofibrate 67mg m/r tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Fenofibrate 134mg m/r tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Fenofibrate 200mg m/r tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Baclofen 10 mg orodispersible tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely baclofen 20 milligram/1 each conventional release orodispersible tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin 81 mg and pravastatin 20 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin 81 mg and pravastatin 40 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin 81 mg and pravastatin 80 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin 325 mg and pravastatin 80 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin 325 mg and pravastatin 40 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin 325 mg and pravastatin 20 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely conjugated estrogens 300 microgram and medroxyprogesterone 1.5 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely conjugated estrogens 450 microgram and medroxyprogesterone 1.5 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely conjugated estrogens 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely conjugated estrogens 625 microgram and medroxyprogesterone 5 milligram/1 each conventional release oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Fenofibrate 54 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Bupropion hydrochloride 300mg m/r tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely fluoxetine hydrochloride 20 milligram/1 each conventional release oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Glipizide 2.5mg m/r tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Metformin hydrochloride 750mg m/r tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Glipizide 2.5 mg and metformin hydrochloride 250 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely glipizide 2.5 milligram and metformin hydrochloride 500 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Glipizide 5 mg and metformin hydrochloride 500 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Metformin hydrochloride 625 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Glucophage 625mg tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Guanidine hydrochloride 125 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Ethinylestradiol 20 microgram and ferrous fumarate 75 mg and norethisterone 1 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely ethinylestradiol 30 microgram and ferrous fumarate 75 milligram and norethisterone 1.5 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Calcium leucovorin 5 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely cinacalcet (as cinacalcet hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Cinacalcet (as cinacalcet hydrochloride) 60 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Cinacalcet (as cinacalcet hydrochloride) 90 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely amlodipine besilate 5 milligram and atorvastatin 10 milligram/1 each conventional release oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely amlodipine besilate 5 milligram and atorvastatin 20 milligram/1 each conventional release oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely amlodipine besilate 5 milligram and atorvastatin 40 milligram/1 each conventional release oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely amlodipine besilate 5 milligram and atorvastatin 80 milligram/1 each conventional release oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely amlodipine besilate 10 milligram and atorvastatin 10 milligram/1 each conventional release oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely amlodipine besilate 10 milligram and atorvastatin 20 milligram/1 each conventional release oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely amlodipine besilate 10 milligram and atorvastatin 40 milligram/1 each conventional release oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)

Start Previous Page 13 of 28 Next End

This concept is not in any reference sets

Back to Start